Furthermore, epitope mapping studies of rat ErbB2/HER2 led to the discovery of several novel helper T epitopes, a subset of which also elicited strong Th1-dominated responses and therapeutic activity in the murine breast cancer model. Here, ERBB2 is linked to breast carcinoma.